Showing results (41-50 of 140) with videos related to
Sort By:
Pageof 14
Journal of Nanoscience and Nanotechnology|July 19, 2016
Enhanced Intracellular Hyperthermia Efficiency by Magnetic Nanoparticles Modified with Nucleus and Mitochondria Targeting PeptidesXiaowen Wang, Jumei Zhou, Benke Chen, et al.Acta Pharmaceutica Sinica. B|April 3, 2025
Beyond cancer: The potential application of CD47-based therapy in non-cancer diseasesWei-Qing Deng, Zi-Han Ye, Zhenghai Tang, et al.Cell Reports|December 15, 2021
Inflammatory macrophages exploit unconventional pro-phagocytic integrins for phagocytosis and anti-tumor immunityZhenghai Tang, Dominique Davidson, Rui Li, et al.Frontiers in Nephrology|September 7, 2023
Case Report: Roxadustat in Combination With Rituximab Was Used to Treat EPO-Induced Pure Red Cell AplasiaXiaoe You, Baochun Guo, Zhen Wang, et al.The Analyst|June 16, 2026
Urchin-like covalent organic framework microspheres for electrochemical organophosphorus pesticide sensingHongze Yao, Tong Lu, Yu Wu, et al.ACS Applied Bio Materials|January 13, 2022
Fluorescence Sensor Array for Discrimination of Urine Proteins and Differentiation Diagnosis of Urinary System DiseasesYishun Shen, Yuanfang Huang, Pangmiaomiao Zhang, et al.ACS Applied Materials & Interfaces|November 25, 2014
Design of two-dimensional, ultrathin MoS₂ nanoplates fabricated within one-dimensional carbon nanofibers with thermosensitive morphology: high-performance electrocatalysts for the hydrogen evolution reactionHan Zhu, FengLei Lyu, MingLiang Du, et al.Molecular Omics|March 17, 2025
Transcriptome profiling of serum exosomes by RNA-Seq reveals lipid metabolic changes as a potential biomarker for evaluation of roxadustat treatment of chronic kidney diseasesRu Zhou, YaXuan Zhen, Hualin Ma, et al.ACS Applied Materials & Interfaces|November 7, 2025
Engineering Cobalt-Doped Nickel Oxide/Gadolinium-Doped Cerium Dioxide Heterojunction Nanofibers for Highly Selective and Sensitive Dopamine DetectionWanchen Xie, Xin Qian, Shuanglong Lu, et al.Cell Communication and Signaling : CCS|December 19, 2022
Docetaxel suppressed cell proliferation through Smad3/HIF-1α-mediated glycolysis in prostate cancer cellsJunming Peng, Zhijun He, Yeqing Yuan, et al.Pageof 14